Yossi Maimon, Vice President & CFO at Protalix BioTherapeutics, Inc. (PLX), bought 10,000 shares at $0.78 ($8K) on 2015-12-14, disclosed to the SEC on 2015-12-15.
Open-market purchase of $8k PLX by Vice President & CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PLX | SELL | 2010-09-08 | $565K | — | Filing → |
| PLX | SELL | 2009-10-19 | $1.4M | — | Filing → |
| PLX | SELL | 2009-07-08 | $255K | — | Filing → |